Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2026-03-06 @ 3:32 PM
Study NCT ID:
NCT01390402
Status:
COMPLETED
Last Update Posted:
2016-02-03
First Post:
2011-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Alloreactive haploidentical NK cells | View |
| None | Natural killer cells | View |
| None | Stem Cell Transplantation | View |
| None | Immune cells | View |
| None | Chronic myelogenous leukemia | View |
| None | CML | View |
| None | Human leukocyte antigen | View |
| None | HLA | View |
| None | Graft-vs-host disease | View |
| None | GVHD | View |
| None | Antithymocyte globulin | View |
| None | ATG | View |
| None | Thymoglobulin | View |
| None | Interleukin-2 | View |
| None | IL-2 | View |
| None | Aldesleukin | View |
| None | Proleukin | View |
| None | Fludarabine | View |
| None | Fludarabine phosphate | View |
| None | Fludara | View |
| None | Tacrolimus | View |
| None | Prograf | View |
| None | Busulfan | View |
| None | Busulfex | View |
| None | Myleran | View |
| None | Methotrexate | View |